2022 update of the drug resistance mutations in HIV-1.
2022 update of the drug resistance mutations in HIV-1.
复制标题
DOI：
--
复制
发表时间：
2022
影响因子：
--
通讯作者：
A. Wensing;Vincent Calvez;F. Ceccherini‐Silberstein;Charlotte Charpentier;H. Günthard;R. Paredes;Robert W. Shafer;D. Richman
中科院分区：
文献类型：
--
作者：
A. Wensing;Vincent Calvez;F. Ceccherini‐Silberstein;Charlotte Charpentier;H. Günthard;R. Paredes;Robert W. Shafer;D. Richman
2022年版的IAS-USA耐药突变清单更新了上次于2019年9月发布的数据。所列的突变是那些根据证据和所述药物的特定标准确定的突变。该图表旨在帮助从业者识别与抗逆转录病毒药物耐药性相关的关键突变，从而做出有关抗逆转录病毒治疗的临床决策。
The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.